The Recall Desk
HighFDA (Devices)·Z-1244-2022·Announced 2022-06-15

FDA Recalls V8 Immunodisplacement Kit Due to Microbial Contamination

Helena Laboratories is recalling the V8 Immunodisplacement Kit (51 units) due to microbial contamination that interferes with test interpretation. The FDA Class II recall affects kits distributed in the U.S. and internationally.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: FDA Class II recall with microbial contamination potentially affecting test result accuracy. No illnesses or injuries reported. Meets High severity criterion as a risk-of-harm product where injury has not yet been reported.

Plain-English summary

Helena Laboratories, Corp. is recalling the V8 Immunodisplacement Kit REF 1803 due to microbial growth that can interfere with test result interpretation. The recall involves 51 kits distributed in the United States and internationally.

The affected kits were distributed to facilities in Florida, Missouri, Ohio, and Texas within the U.S., and to Canada, Uruguay, and Vietnam internationally. Affected lot numbers are 3-21-1803 and 1-22-1803.

This Class II medical device recall was issued by the FDA because microbial contamination can compromise the reliability of test results produced by the kit. The contamination causes interference with the interpretation of diagnostic findings.

The recalled product

Product
V8 Immunodisplacement Kit REF 1803
Manufacturer
Helena Laboratories, Corp.
Hazard
  • microbial-contamination
  • test-interference

Distribution

Distributed in 4 states:

  • FL
  • MO
  • OH
  • TX